TipRanks on MSN

Incyte’s Latest Clinical Study: A Step Forward in Drug Development

Incyte (($INCY)) announced an update on their ongoing clinical study. Incyte Corporation is currently conducting a clinical study titled ‘An ...
The Malaysian Reserve

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

NetworkNewsWire Editorial Coverage NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The global oncology market is rapidly shifting ...
TipRanks on MSN

Pfizer’s New Study on Drug Interactions: What Investors Need to Know

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has launched a Phase 1 clinical study titled ‘AN ...
Le Lézard

Edison Oncology Presents Two Posters at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Novel targeted therapies for ARID1A-mutant and CDA-resistant cancers highlighted MENLO PARK, CA / ACCESS Newswire / October 27, 2025 / Edison Oncology, a clinical-stage biopharmaceutical company ...